Rootine Recognized in Fast Company’s 2023 World Changing Ideas Awards Honorable Mention in Wellness Category
The winners of Fast Company’s 2023 World Changing Ideas Awards were announced today, honoring sustainable designs, innovative products, bold social initiatives, and other creative projects that are changing the way we work, live, and interact with the world. Rootine earned an…
ModMed celebrates 10 years of its award-winning ophthalmology solutions
ModMed is celebrating 10 years of its award-winning ophthalmology solutions at the ASCRS-ASOA Annual Meeting, in San Diego, while also looking ahead to the future. “For 10 years, ModMed Ophthalmology has provided industry-leading healthcare IT to help ophthalmologists save time and…
Altera Digital Health and Pipeline Health Extend Partnership by Seven Years
Altera Digital Health, a global healthcare IT innovator, today announced it has expanded its partnership with Pipeline Health, a community-based hospital system headquartered in Los Angeles. The seven-year contract will extend Pipeline Health’s use of the Paragon electronic health record (EHR) at four…
Spesana Launches Advisory Board to Support Company Growth
Spesana has announced the formation of the Spesana Advisory Board with appointments of experienced industry leaders across clinical sites, life science companies and diagnostic labs. The Advisory Board will collaborate on strategy for multiple healthcare stakeholders’ use of the Spesana…
Vivasure Medical Announces Enrollment of First Patients in Pivotal PATCH Study
a company pioneering novel fully absorbable technology for percutaneous vessel closure, today announced it has enrolled the first patients in the company’s PerQseal® PATCH Clinical Study, a multi-center, single-arm, pivotal study evaluating the safety and efficacy of the Vivasure PerQseal Closure…
The Dreyfus Prize in the Chemical Sciences Winner Announced
The Camille and Henry Dreyfus Foundation has announced that Xiaowei Zhuang, Howard Hughes Medical Institute Investigator and David B. Arnold Jr. Professor of Science, Harvard University, is the recipient of the 2023 Dreyfus Prize in the Chemical Sciences. The international biennial…
Global mRNA Synthesis Raw Materials Market Report 2023: Increasing Funding For mRNA Research Drives Growth – ResearchAndMarkets.com
The global mRNA synthesis raw materials market size is projected to reach USD 3.3 billion by 2030. The market is expected to expand at a CAGR of 2.1% from 2023 to 2030. The major factors driving the market growth include…
Results from Pivotal Phase 3 ATTACK Trial of Investigational Sulbactam-Durlobactam for Treatment of Serious Infections Caused by Acinetobacter Published in The Lancet Infectious Diseases
Innoviva Specialty Therapeutics, a subsidiary of Innoviva, Inc. (Nasdaq: INVA) focused on delivering innovative therapies in critical care and infectious disease, today announced that The Lancet Infectious Diseases published detailed results from the pivotal Phase 3 ATTACK trial of sulbactam-durlobactam, the first…
Navidea Biopharmaceuticals, Inc. Promotes Michael Sherman Blue, M.D., FACEP, to Chief Medical Officer
Navidea Biopharmaceuticals, Inc. (NYSE American: NAVB) (“Navidea” or the “Company”), a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, today announced the promotion of Michael Sherman Blue, M.D., FACEP to the position of Chief Medical Officer (CMO),…
Scientist.com erwirbt Labs Explorer und führt schnelle Expansion in den europäischen Forschungsmarkt fort
Scientist.com, der führende Marktplatz für präklinische Forschung für den biopharmazeutischen Sektor, gab heute die kürzliche Übernahme von Labs Explorer bekannt, einem bekannten französischen Netzwerk, das europäische Forschungslabore, wissenschaftliche Fachleute und innovative Start-ups miteinander verbindet. Dieser strategische Schritt verschafft den Nutzern…
FOXO Technologies™ Announces First Quarter 2023 Financial Results
FOXO Technologies Inc. (NYSEAM: FOXO) (“FOXO” or the “Company”), a leader in commercializing epigenetic biomarkers of health and aging, today reported financial results for the first quarter ended March 31, 2023. “The first quarter was a strong start to the…
Lineage Cell Therapeutics Reports First Quarter 2023 Financial Results and Provides Business Update
a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, today reported financial and operating results for the first quarter ended March 31, 2023 and will host a conference call today at 4:30 p.m. Eastern Time to discuss…